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Abstract 
Purpose: To evaluate the antibiotic susceptibility pattern of various bacterial pathogens including 
extended spectrum betalactamase (ESBL) producers in Kano, Nigeria. 
Method: A total of 604 consecutive clinical samples obtained from Aminu Kano Teaching Hospital 
(AKTH), Kano between January and July 2010 were analyzed for bacterial pathogens using standard 
microbiological techniques for the isolation and identification of pathogens. Antibiotics susceptibility 
tests including, ESBL screening and confirmation, were carried out by disc diffusion technique using 
Clinical Laboratory Standard Institute (CLSI) criteria. 
Results: Ten different types of bacteria genera were observed from nine different clinical samples. E. 
coli was the most frequently isolated bacteria (30.5 %) followed by Staphylococcus aureus (21.3 %). 
ESBL producers showed high-level resistance against the quinolones, aminoglycoside and 
cotrimoxazole but were sensitive to carbapenems and levofloxaccin. Non-ESBL organisms showed 
increased resistance to amoxicillin-clavulanate, ceftazidime, cotrimoxazole, tetracycline and amoxycillin. 
The prevalence of ESBL producers was 12.8 %. E. coli, Klebsiella pneumonia and Pseudomonas 
aeruginosa showed ESBL production of 17.3, 14.9 and 10.0 %, respectively. 
Conclusion: The findings of this study suggest that regular surveys should be carried out in this locality 
to provide baseline data that would always be of clinical relevance in the treatment of patients and to 
detect the emergence of multiple antibiotic resistance strains. 
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Before the discovery of penicillin, which initiated 
the antibiotic era, the prognosis for people with 
infectious diseases, such as bacterial 
pneumonia, tuberculosis and staphylococcal 
infections, was poor [1]. Today antibiotics are 
widely prescribed for various bacterial infections 
with a high degree of success. However, the 
unfortunate outcome of the wide-scale use of 
antibiotics is the development of antimicrobial 
resistance, an adaptive response in which 
microorganisms begin to tolerate an amount of 
drug to which it was previously susceptible. The 
development of mechanisms for circumventing or 
inactivating antibiotic drugs is due largely to the 
genetic versatility and adaptability of microbial 
populations [2].  
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Beta-lactam antimicrobial agents are the most 
common drugs for the treatment of bacterial 
infections and account for over 50 % of global 
antibiotic consumption [3]. Bacterial resistance to 
B-lactam antibiotics has significantly increased in 
recent years and has been attributed to the 
spread of plasmid mediated B-lactamases. Some 
of these organisms have produced new forms of 
the older enzymes such as the extended-
spectrum B-lactamases (ESBLs) that can 
hydrolyze newer celphalosporins and aztreonam 
[4]. 
 
Extended-spectrum b-lactamases (ESBLs) 
represent an important mechanism of resistance 
in Enterobacteriacaeae, because they inactivate 
penicillin, narrow- and extended-spectrum 
cephalosporins, and aztreonam [5]. This study is 
focused on the prevalence and antibiotic 
susceptibility pattern of ESBL producers in 
bacterial isolates of urogenital infections and 






MacConkey agar, Blood agar base, Mueller 
Hinton agar, Salmonella Shigella agar were all 
manufactured by Oxoid, Bassingoke, United 
Kingdom. The antibiotic discs; ofloxacin 15 µg, 
ceftazidime 30 µg, ceftriazone 30 
µg,ciprofloxacin 10 µg, amoxicillin/clavulanate 30 
µg, gentamicin 10 µg, levofloxacin 10 µg, 
amoxycillin 30 µg, erythromycin 15µg, 
cotrimoxazole 25 µg, and cloxacillin 10 µg (all 
from Abbot Laboratories, UK) were placed after 
the plates were confirmed to have dried, and 
incubated for 18 - 24 h. E. coli ATCC 25922, 
Pseudomonas aeruginosa ATCC 27853, S. 




A total of 604 clinical samples as listed above 
obtained from patients at Amino Kano teaching 
Hospital from various service points between 
January and July 2010 were analyzed for 
bacterial pathogens by standard microbiological 
procedures [6]. 
 
The clinical samples consisted of the following: 
urine (N = 302), wound swab (N = 151), ear 
swabs (N = 78), catheter tips (N = 34), semen (N 
= 3), endocervical swabs (N = 12), throat swabs 
(N = 3) and umbilical cord swab (N = 6). 
 
The samples were inoculated on blood and 
MacConkey agar. Salmonella Shigella agar was 
included for enteric pathogens. All were 
incubated aerobically at 37 oC for 18 - 24 h. 
Anaerobic culture was not carried out. Gram 
stain, motility and biochemical tests were used to 
identify the various isolates. 
 
Antibiotic susceptibility test 
 
This was carried out by disc diffusion technique, 
(WHO modified) in accordance with the CLSI 
criteria and interpreted accordingly [7]. Mueller 
Hinton culture plates were inoculated by dipping 
a sterile cotton wool swab into a suspension of 
the overnight growth of the organism prepared to 
the density of a Mc Farland no 0.5 opacity 
standard; excess liquid from the swab was 
expressed before inoculation by spread plate 
method. 
  
ESBL producers-screening and confirmation 
 
The isolates were tested against third generation 
cephalosporins (cefodoxime, cefotaxime and 
ceftriaxone) using Clinical Laboratory Standard 
Istitute (CLSI) recommended, WHO modified 
Kirby Bauer disc diffusion method [8]. Zone 
diameters were interpreted using the revised 
National Committee on Clinical Laboratory 
(NCCL) Standard document [14]. Isolates with 
reduced susceptibility to cefpodoxime (≤ 17 mm) 
cefotaxime (≤ 27 mm) and ceftriaxone (≤ 25 mm) 
were considered to be possible ESBL producers. 
 
Phenotypic confirmation test was carried-out 
using Double Disc Synergy test. Disc containing 
the standard 10 ug of cefpodoxime and 30 ug of 
ceftazidime/ceftriaxone, are placed 15 mm apart 
(edge to edge); with amoxicillin-clavulanic acid 
disc containing 10 ug of the latter compound 
mounted exactly at their center. After 16 - 20 h of 
incubation at 35 oC, any enhancement of the 
zone of inhibition between a beta-lactam disk 
and that containing the beta-lactamase inhibitor 




The data were computed as mean and standard 
deviation as well as in percentage. Chi-square 
analysis was carried out by Epi info Version 6 





The age group prevalence of infected patients is 
presented on Table 1. The age group that had 
the highest number of isolates was 0 - 10 years 
(27.8 %) while > 70 years (0.9 %) had the least. 
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The difference was statistically significant X2 = 
356.9, df = 7, p < 0.001. 
 
Table 1: Prevalence by age of infected patients  
  
Age (years) N Prevalence (%) 
0-10 168 27.8 
11-20 71 11.8 
21-30 166 27.5 
31-40 78 12.9 
41-50 47 7.7 
51-60 35 5.8 
61-70 33 5.5 
>70 6 0.9 
X2 = 356.9, df = 7, p < 001 
 
Table 2 shows the distribution of bacterial 
pathogens by clinical samples and gram staining 
reactions. 75 % of the isolates showed gram 
negative result while 24.8 % were Gram positive 
cocci. Urine sample constituted the largest 
number of specimens (50 %) followed by wound 
swab (25 %). E. coli was the most frequently 
isolated organism (30.5 %) followed by S. aureus 
(21.3 %). 
 
The antibiotic susceptibility data for the bacterial 
pathogens, which shows high level of resistance 
against various antibiotics, are presented in 
Table 3. 
 
Most pathogens were resistant to commonly 
used antibiotics such as tetracycline, 
cotrimoxazole and amoxycillin. E. coli and 
Klebsiella pneumonia showed 14 and 16 % 
susceptibility respectively against 
amoxicillin/clavulanate and 43 and 21 % 
respectively against ceftazidime. However, 
ceftriaxone, gentamicin and levofloxacin showed 
over 60 % susceptibility against most bacterial 
pathogens. 
Table 4 shows the percentage prevalence of 
extended spectrum beta-lactamase producers 
among urogenital pathogens. 
 
E. coli had the highest prevalence of 17.3 % 
followed by Klebsiella pneumonia 14.9 % while 
the least was Proteus vulgaris 2.4 %. The 
difference however, was not statistically 
significant (X2 = 9.22, df = 4, p = 0.05). 
 
The antibiotic susceptibility pattern of ESBLs 
against six antibiotics is presented in Table 5. 
Besides exhibiting high level resistance against 
the cephalosporins, these pathogens also show 
resistance to other groups of antibiotics such as 
the aminoglycoside, fluoroquinolones and 
cotrimoxazole. 
 
However, the cabapenemes and levofloxacins 





The prevalence of resistance to antibiotics varies 
greatly from one geographical area to another as 
well as between hospitals within community, 
mainly because of the differences in antimicrobial 
usage and infection control practices [10]. 
  
The age group prevalence of high infectious rate 
observed in infants and older children when 
exposed to bacterial pathogens could be 
attributed  to  their  low  level  of  immunity,  other 
researchers made similar observations in their 
reports [11]. The majority of the bacterial isolates 
75.2 %, observed in the study were Gram 
negative bacilli mainly of the Enterobacteriaceae.  
 
 
Table 2: Distribution of bacterial pathogens by clinical samples and Gram-staining reactions 
 
Isolate UR CT ES WS ST ECS TS SM UBC Total % 
Gram-negative 
E. coli 136 9 20 15 0 5 0 0 1 186 30.5 
K. pneumonia 58 3 10 10 0 6 1 2 0 90 14.8 
P. mirabilis 25 3 10 10 0 1 0 0 0 49 9.0 
P. vulgaris 39 0 7 2 0 0 1 1 0 50 8.2 
P. aeruginosa 24 9 16 10 0 0 1 0 0 60 9.8 
Enteropathic E. coli 0 0 0 0 10 0 0 0 0 10 1.6 
Salmonella typhi 0 0 0 0 5 0 0 0 0 5 0.8 
Enterobacter Spp 2 0 0 0 0 0 0 0 0 2 0.3 
M. morgani 1 0 0 0 0 0 0 0 0 1 0.2 
S. marcescens 1 0 0 0 0 0 0 0 0 1 0.2 
Gram-positive            
E. faecalis 16 0 0 4 0 0 0 0 0 20 3.3 
S. aureus 0 10 15 100 0 0 0 0 5 130 21.3 
Total 302 34 78 151 15 12 3 3 6 604  
Key: UR = urine, CT = catheter tip, ES = ear swab, WS = wound swab, ST = stool, ECS = endocervical swab, TS 
= throat swab, SM = semen, UBC = umbilical cord swab 
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This is in agreement with the reports of other 
researchers [12]. E. coli (30.5 %) was the most 
frequently isolated. It also accounted for most of 
all urinary isolates giving 45.0 %. This 
observation is in agreement with the findings of 
other research workers [13]. The preponderance 
of this organism may be due to the fact that it 
constitutes a large proportion of the intestinal 
flora and with low hygienic practices, it will be 
expected to be isolated in diseases such as 
urinary tract infection, wound infections and other 
bacterial infections. 
 
The prevalence of ESBL producers in this study 
was 12.8 %, which is higher than an earlier study 
in Kano [14] that reported 9.25 %, but much 
lower than a report of 36.2 % from Ebonyi State 
in Nigeria [15]. However, these results are higher 
than the report of 2.6 % from researchers in 
Bosnia and Herzegovina [16], and also 8.9 % 
from Saudi Arabia [17]. These may be attributed 
to different cultures of antibiotic usage in states 
where studies were carried out. 
 
E. coli and Klebsiella pneumoniae showed 
ESBLs prevalence of 17.3 % and 14.9 % 
respectively in the present study. These values 
were lower than the reports from India [18]. 
However, both reports are at variance with 
another report from Nigeria [19] in which 
Klebsiella pneumoniae had ESBL prevalence of 
35.3 % while E. coli had 27.3 %. The antibiotic 
susceptibility of ESBL E. coli was 46.1, 7.6, 30.8 
and 57.7 % when tested against gentamicin, 
cotrimoxazole, ciproflaxacin and levofloxacin 
respectively. Against imipenem and meropenem 
ESBL producing E. coli showed an antibiotic 
susceptibility of 69.2 % and 61.5 %, respectively. 
Other researchers [20] also reported 
encouraging antibiotic susceptibility result with 
imipenem and meropenem. 
 
The predominating presence of S. aureus (76.9 
%) on the isolates in wound swab, agrees with 
earlier reports [21]. It is important to mention that 
its high level resistance characteristics observed 
in this study is also in agreement with other 
reports [22].  S. aureus showed antibiotic 
susceptibility of 30.8, 3.8, 23, 0, 0, 0 and 45.2 % 
when tested with amoxicillin/clavulanate, 
ceftazidime, ceftriaxone, cotrimoxazole, 
tetracyclin, amoxicillin and cloxacillin. E. coli was 
also observed to have shown very poor 
susceptibility to all the antibiotics mentioned 
which are all routine and commonly used drugs  
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Table 4: Prevalence of extended-spectrum betalactamase (ESBL) producers among Gram-negative urogenital 
pathogens 
 
Bacteria isolate No. of isolates screened Positive Negative Prevalence 
(%) 
E. coli 150 26 124 17.3 
Klebsiella pneumoniae 67 10 57 14.9 
Proteus mirabilis 29 2 27 6.8 
Proteus vulgaris 41 1 40 2.4 
Pseudomonas aeruginosa 33 2 31 6.0 
Total 320 41 280 12.8 
X2=9.22, df = 4, p = 0.05 
 
Table 5: Antibiotic susceptibility pattern of ESBL producers 
 
Pathogen No. of 
isolates 
Sensitive isolates N(%) 
CN COT CIP IMP MEP LEV 
E. coli 26 12(46.1) 2(7.6) 8(30.8) 18(69.2) 16(61.5) 15(57.7) 
Klebsiella pneumonia 10 5(50) 0(0) 4(40) 7(70) 6(60) 6(60) 
Proteus mirabilis 2 0(0) 0(0) 0(0) 0(0) 1(50) 1(50) 
Proteus vulgaris 1 0(0) 0(0) 0(0) 0(0) 0(0) 1(100) 
Pseudomonas aeruginosa 2 1(50) 0(0) 0(0) 1(50) 0(0) 1(50) 
Key:  CN = gentamicin, COT = cotrimoxazole, CIP = ciprofloxacin, IMP = imipenem, MEP = meropenem, LEV = 
levofloxacin 
 
that are completely losing their efficacy against 
increasing wave of bacterial resistance. 
 
Many clinical laboratories (as well as the wider 
medical community) are not fully aware of the 
importance of ESBLs and how to detect them; 
laboratories may also lack the resources to curb 
the spread of these resistance mechanisms [23]. 
This ignorance and possible financial constraints 
may be responsible for the continuous 
dissemination of ESBLs worldwide. 
 
Despite the rapidity with which new 
chemotherapeutic agents are introduced, 
bacteria have shown a remarkable ability to 
develop resistance to these agents. In view of 
the steady rise in bacteria resistance to 
antibiotics, it has become very important to carry 





Regular studies of the antibiotic susceptibility 
pattern of isolates commonly observed in a 
locality will guide therapeutic judgment and 
enhance antibiotic prescribing. Such surveys will 
yield the first clue when multi drug resistant 
isolates are encountered to prevent therapeutic 
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